Clinical trials
Completed Phase 3 Myasthenia Gravis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
33 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2004 | 2 |
| 2006 | 3 |
| 2007 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2016 | 1 |
| 2018 | 3 |
| 2019 | 6 |
| 2021 | 5 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 33 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| UCB Biopharma SRL | 7 |
| Alexion Pharmaceuticals, Inc. | 5 |
| argenx | 5 |
| Astellas Pharma Inc | 3 |
| Harbour BioMed (Guangzhou) Co. Ltd. | 2 |
| Benesis Corporation | 1 |
| Catalyst Pharmaceuticals, Inc. | 1 |
| FDA Office of Orphan Products Development | 1 |
| First Affiliated Hospital, Sun Yat-Sen University | 1 |
| Fredrik Piehl | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Myasthenia Gravis | 33 |
| Autoimmune Diseases | 1 |
| Muscle Weakness | 1 |
| Thymoma | 1 |
Trials
Showing 1 to 25 of 33. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.